Management of side effects of mTOR inhibitors in tuberous sclerosis patients.
about
mTOR and MAPK: from localized translation control to epilepsyDisulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cells.Normalizing translation through 4E-BP prevents mTOR-driven cortical mislamination and ameliorates aberrant neuron integration.Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guide.Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase ActivityTFEB activation restores migration ability to Tsc1-deficient adult neural stem/progenitor cells.Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies.Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies.Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches.
P2860
Q28076827-2C2468C6-F31A-400F-9EF1-E6ECD7CA058EQ33709971-790F51E4-450F-4218-B970-CBE6AFDC6C63Q37323116-0787CAD5-9107-44F7-8362-1447E53A581FQ37644172-209CC129-AD54-44FF-B77A-F31DC216E57BQ37661161-1F6E29FB-A68F-4120-8F32-D6F3C8267E03Q38715345-8FE7A1B0-AF48-47B5-90FE-805BD61C4440Q38793867-CF0B9AF3-E55A-4500-A2A6-19BAC49C69F9Q38815881-46528D17-9FC6-4C59-ABEC-59C8E8C29AC9Q38994919-1875ADA5-37D8-425D-8317-4F571981AC53
P2860
Management of side effects of mTOR inhibitors in tuberous sclerosis patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Management of side effects of mTOR inhibitors in tuberous sclerosis patients.
@en
type
label
Management of side effects of mTOR inhibitors in tuberous sclerosis patients.
@en
prefLabel
Management of side effects of mTOR inhibitors in tuberous sclerosis patients.
@en
P50
P1476
Management of side effects of mTOR inhibitors in tuberous sclerosis patients.
@en
P2093
Katarzyna Kotulska
Krzysztof Sadowski
P304
P356
10.1016/J.PHAREP.2016.01.005
P577
2016-01-22T00:00:00Z